Belarus pharma market has long-term growth potential but problems short-term

All indicators point to a period of prolonged economic and political upheaval in Belarus, with the pharmaceutical market battered by a combination of high inflation and currency devaluation through to the end of the year, according to Business Monitor International.

The market retains significant long-term growth potential, although much will depend on how quickly the economy, long managed by the quixotic President Alexander Lukashenko, is able to find a new equilibrium. In the short to medium term, with the pending liquidation of state-controlled giant Belbiopharm, deep uncertainty will likely deter even the hardiest investors. .

Headline expenditure projections